FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 15:41:39 2024-06-14 EDT | ||
| 6.45 EUR | -0.92% |
|
| Current month | -8.46% | ||
| 1 month | -17.11% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 6.49 | -0.31% |
| 24-06-13 | 6.51 | -1.66% |
| 24-06-12 | 6.62 | -1.19% |
| 24-06-11 | 6.7 | -3.60% |
| 24-06-10 | 6.95 | -1.56% |
Real-time Boerse Frankfurt Warrants
Last update June 14, 2024 at 03:41 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB01J5 |
| ISIN | DE000SB01J56 |
| Date issued | 2020-06-09 |
| Strike | 225.5 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.86 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.48 € |
|---|---|
| Lowest since issue | 2.74 € |
| Spread | 0.03 € |
| Spread % | 0.46% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Certificates
- Certificat
